Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Daniela Russo

6PUBLICATIONS

47CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Dec 19, 2025

CCDC6 Immunostaining in Conjunction with the Rad51 HRD Assay May Expand PARPi Treatment Eligibility in Patients with HGSOC.

Daniela Criscuolo, Francesco Merolla, Benedetta Pellegrino

|Sep 23, 2022

Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab.

Marina Fabbi, Delfina Costa, Daniela Russo

|Apr 12, 2022

Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients.

Crescenzo D'Alterio, Anna Spina, Laura Arenare

|Jan 21, 2022

AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization.

Eros Azzalini, Domenico Tierno, Michele Bartoletti

|Aug 18, 2020

PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives.

Lucia Musacchio, Giuseppe Caruso, Carmela Pisano

|Apr 11, 2020

Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience.

Daniela Califano, Daniela Russo, Giosuè Scognamiglio

Pageof 1

Frequent Collaborators

5 joint publications

Daniela Califano

2 joint publications

Delia Mezzanzanica

2 joint publications

Sandro Pignata

2 joint publications

Giosuè Scognamiglio

2 joint publications

Vincenzo Canzonieri

2 joint publications

Simona Signoriello

2 joint publications

Paolo Chiodini

1 joint publications

Loris De Cecco

1 joint publications

Giuseppe Caruso

1 joint publications

Innocenza Palaia

Frequent Collaborators

5 joint publications

Daniela Califano

2 joint publications

Delia Mezzanzanica

2 joint publications

Sandro Pignata

2 joint publications

Giosuè Scognamiglio

Top Related Videos

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications

Published on : Apr 21, 2023

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

See more related videos

Top Related Videos

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications

Published on : Apr 21, 2023

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

See more related videos